Syria’s First Lady To Withdraw From Public Duty To Treat Leukaemia – Presidency
Joy ChukwuMay 21, 20241 Mins read747 
Asma al-Assad, Syria’s first lady, has been diagnosed with leukaemia, the Syrian presidency announced in a statement on Tuesday.
“First Lady Asma al-Assad has been diagnosed with acute myeloid leukaemia,” the statement read.
It revealed that she “will undergo a specialised treatment protocol” that requires social distancing to avoid infection, adding that she will “temporarily withdraw from all direct engagements as part of her treatment plan”.
Acute myeloid leukaemia is an aggressive cancer of the bone marrow and the blood.
Assad has previously been treated for breast cancer. In August 2019, she announced that she was “completely” free of the disease a year after her diagnosis.
About The Author
Related Articles
Niger’s Tiani Sets Out “Security First” Doctrine at AES Summit, Signals Complete Break from Old Order
At the AES summit bringing together Burkina Faso, Mali, and Niger, Niger’s...
AES Confederation Launches Television Network in Push for Media Sovereignty
Meeting in Bamako, the three Heads of State of the Confederation of...
Gold Sector Revival Expected to Drive Mali Growth Next Year
The International Monetary Fund has projected that Mali’s economy will return to...
Burkina Faso, Mali and Niger Formalise New Regional Security Alliance
Burkina Faso, Mali and Niger have formally launched a joint regional military...